Tag: Accelrys

  • Overbought Stocks: HDFC Bank (NYSE:HDB), Banro Corporation (NYSEMKT:BAA), Orthofix International (NASDAQ:OFIX), Accelrys (NASDAQ:ACCL)

    Although HDFC Bank Limited (NYSE:HDB) is up over 15.5% in the past four weeks, investors may be concerned. After all, HDB is now in overbought territory, at least when looking at its RSI value of 72.5. HDFC Bank Limited (ADR) (NYSE:HDB) shares after opening at $40.60 moved to $40.97 on last trade day and at the end of the day closed at $40.39. Company price to sales ratio in past twelve months was calculated as 5.16 and price to cash ratio as 7.03. HDFC Bank Limited (ADR) (NYSE:HDB) showed a positive weekly performance of 4.96%.

    Banro announces on March 27 a Mineral Reserve Estimate at its Namoya Gold Mine, Democratic Republic of the Congo. Banro Corporation (USA) (NYSEMKT:BAA) shares ended the day on $0.511. BAA return on equity ratio is recorded as 1.20% and its return on assets is 0.80%. Banro Corporation (USA) (NYSEMKT:BAA) yearly performance is 538.75%.

    Orthofix International NV (NASDAQ:OFIX) managed to report a decline in revenue in the full-year 2013 compared with 2012. Revenue came in at $400.5 million, lower than the comparable year by 11 percent. Orthofix International NV (NASDAQ:OFIX) shares moved down -0.30% in last trading session and was closed at $30.29, while trading in range of $29.82 – $31.09. Orthofix International NV (NASDAQ:OFIX) year to date (YTD) performance is 32.73%.

    Accelrys, Inc. (NASDAQ:ACCL), a leading provider of scientific innovation lifecycle management software and solutions, announced that David B. Agus, MD, one of the world’s leading cancer doctors, researchers, medical futurists and technology innovators, will present the keynote address at the Accelrys user conference, Accelerate2014, which is being held from May 19-23 at the Grand Hyatt Washington, D.C. Accelrys, Inc. (NASDAQ:ACCL) weekly performance is -0.16%. On last trading day company shares ended up $12.46. Accelrys, Inc. (NASDAQ:ACCL) distance from 50-day simple moving average (SMA50) is 3.58%. Analysts mean target price for the company is $12.60.